FindMyKOL
Clinical trialNCT00426764CompletedPhase 2Interventional

A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma

SponsorCelgeneEnrollment131Peripheral T-cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the activity of romidepsin in patients with progressive or relapsed peripheral T-cell lymphoma (PTCL) who have already been treated with systemic therapy.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

90 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Mater Private Medical Centre - Haematology and Oncology Clinics of Australasia Research Centre

    South Brisbane, Queensland, Australia

  • Peter Maccallum Cancer Centre

    East Melbourne, Australia

  • St. Vincent Hospital

    Fitzroy, Australia

  • Royal North Shore Hospital

    St Leonards, Australia

Czechia
  • University Hospital Brno

    Brno, Czechia

  • University Hospital Hradec Kralove

    Hradec Králové, Czechia

  • Charles University General Hospital

    Prague, Czechia

  • University Hospital of Kralovske Vinohrady

    Prague, Czechia

France
  • Polyclinique Bordeaux Nord Aquitaine

    Bordeaux, France

  • Hopital Henri Mondor

    Créteil, France

  • Hopital Claude Huriez

    Lille, France

  • Chu Nantes Hotel Dieu

    Nantes, France

  • Hopital Saint-Louis

    Paris, France

  • Service Des Maladies Du Sang

    Pessac, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, France

  • Centre Eugene Marquis

    Rennes, France

  • Centre Henri Becquerel

    Rouen, France

Germany
  • Charite Universitatsmedizin Berlin Campus Virchow Klinikum Centrum Fur Tumormedizin

    Berlin, Germany

  • Uniklinik Koln

    Cologne, Germany

  • Krankenhaus Nordwest

    Frankfurt a.M., Germany

  • Georg-August-Universität Göttingen

    Göttingen, Germany

  • Klinikum Der Universitat Munchen-Grosshadern

    München, Germany

  • Klinikum Nurnberg Nord

    Nuremberg, Germany

  • Ukt Universitaetsklinikum Tuebingen

    Tübingen, Germany

Poland
  • Klinika Hematologii Akademickie Centrum Kliniczne Akademii Medycznej W Gdansku

    Gdansk, Poland

  • Oddzial Kliniczny Kliniki Hematologii

    Krakow, Poland

  • Wojewodzki Szpital Specjalistczny Im. Mikolaja Kopernika

    Lodz, Poland

  • Klinika Nowotworow Ukladu Chlonnego

    Warsaw, Poland

Spain
  • Hospital Universitario Vall D Hebron

    Barcelona, Spain

  • Hospital Universitario la Paz

    Madrid, Spain

  • Hospital de la Princesa

    Madrid, Spain

  • Clinica Universitaria de Navarra

    Pamplona, Spain

  • Hospital Universitario de Salamanca

    Salamanca, Spain

  • Hospital Marques de Valdecilla

    Santandar, Spain

Sweden
  • Lund University Hosptial

    Lund, Sweden

  • Akademiska Sjukhuset

    Uppsala, Sweden

Ukraine
  • Dnipropetrovsk State Medical Academy

    Dnipropetrovsk, Ukraine

  • National Cancer Institute Department of Conservative Methods of Treatment

    Kyiv, Ukraine

  • R.E.Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology

    Kyiv, Ukraine

  • Institute of Blood Pathology and Transfusion Medicine of the Ams of Ukraine

    Lviv, Ukraine

50 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Jun 2007
Primary completion
11 Nov 2010
Completion
17 May 2018
Last update posted
11 Feb 2020
Registered enrollment
131
Registry id
NCT00426764

Cross-registrations

EU-CTR / CTIS (EudraCT)2006-006228-21

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.